| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-10 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-08 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-08 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.22 | 1e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.22 | 3e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-06 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |